Evotec and Celgene Enter into Strategic Oncology Partnership
Go back to Evotec and Celgene Enter into Strategic Oncology Partnership| EATON VANCE TAX-ADVANTAGED DIVIDEND INCOME FUND (NYSE: EVT) | Delayed: 29.11 +0.20 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.91 | 52 Week High | $21.25 | |||
| Open | $29.15 | 52 Week Low | $16.37 | |||
| Day High | $29.19 | P/E | N/A | |||
| Day Low | $29.00 | EPS | $0.00 | |||
| Volume | 73,238 | |||||
| Evotec Aktiengesellschaft American Depositary Share (AMEX: EVTCY) | Delayed: 22.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.96 | 52 Week High | $11.93 | |||
| Open | $22.96 | 52 Week Low | $6.56 | |||
| Day High | $22.96 | P/E | N/A | |||
| Day Low | $22.96 | EPS | $0.00 | |||
| Volume | 1,020,350 | |||||
